JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1987; 10:756-760
© 1987 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, S.
Right arrow Articles by Gerstenblith, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, S.
Right arrow Articles by Gerstenblith, G

Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina

SO Gottlieb, ML Weisfeldt, P Ouyang, ED Mellits, and G Gerstenblith

Department of Medicine, Francis Scott Key Medical Center, Baltimore, Maryland 21224.

Silent myocardial ischemia as detected on Holter electrocardiographic (ECG) monitoring is present in greater than 50% of patients with unstable angina despite intensive medical therapy. The presence and the extent of silent ischemia have been correlated with an increased risk of early (1 month) unfavorable outcome including myocardial infarction and need for coronary revascularization for persistent symptoms. Seventy patients with unstable angina who had undergone continuous ECG monitoring for silent ischemia were followed up for 2 years; 37 patients (Group I) had Holter ECG evidence of silent ischemia at bed rest in the coronary care unit during medical treatment with nitrates, beta-receptor blockers and calcium channel antagonists; the other 33 patients (Group II) had no ischemic ST segment changes (symptomatic or silent) on Holter monitoring. Over a 2 year follow-up period, myocardial infarction occurred in 10 patients in Group I (in 2 it was fatal) compared with one nonfatal infarction in Group II (p less than 0.01 by Kaplan-Meier analysis); revascularization with either coronary bypass surgery or angioplasty for symptomatic ischemia was performed in 11 Group I and 5 Group II patients (p less than 0.05). Multivariate Cox's hazard analysis demonstrated that the presence of silent ischemia was the best predictor of 2 year outcome. Therefore, persistent silent myocardial ischemia despite medical therapy in patients with unstable angina carries adverse prognostic implications that persist over a 2 year period.


This article has been cited by other articles:


Home page
CirculationHome page
B. J. Drew, R. M. Califf, M. Funk, E. S. Kaufman, M. W. Krucoff, M. M. Laks, P. W. Macfarlane, C. Sommargren, S. Swiryn, and G. F. Van Hare
Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses
Circulation, October 26, 2004; 110(17): 2721 - 2746.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B L Norgaard, K Andersen, K Thygesen, J Ravkilde, P Abrahamsson, L Grip, and M Dellborg
Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring
Heart, July 1, 2004; 90(7): 739 - 744.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
R. Moreno, A. Villate, J. Zamorano, C. Almeria, J.-A. Perez-Gonzalez, J.-L. Rodrigo, L. P. de Isla, L. Mataix, and C. Macaya
Identifying patients without favourable long-term outcome among those with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram
Eur J Echocardiogr, June 1, 2004; 5(3): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. F. Cohn, K. M. Fox, and C. Daly
Silent Myocardial Ischemia
Circulation, September 9, 2003; 108(10): 1263 - 1277.
[Full Text] [PDF]


Home page
CirculationHome page
S. G. Goodman, D. Fitchett, P. W. Armstrong, M. Tan, A. Langer, and for the Integrilin and Enoxaparin Randomized Asses
Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide
Circulation, January 21, 2003; 107(2): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
M. G. Adams-Hamoda, M. A. Caldwell, N. A. Stotts, and B. J. Drew
Factors to Consider When Analyzing 12-Lead Electrocardiograms for Evidence of Acute Myocardial Ischemia
Am. J. Crit. Care., January 1, 2003; 12(1): 9 - 16.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Kennon, C P Price, P G Mills, P K MacCallum, J Cooper, J Hooper, H Clarke, and A D Timmis
Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers
Heart, January 1, 2003; 89(1): 36 - 41.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
M. M. Pelter, M. G. Adams, and B. J. Drew
Association of Transient Myocardial Ischemia With Adverse In-Hospital Outcomes for Angina Patients Treated in a Telemetry Unit or a Coronary Care Unit
Am. J. Crit. Care., July 1, 2002; 11(4): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B.J. Drew, M.M. Pelter, and M.G. Adams
Frequency, characteristics, and clinical significance of transient ST segment elevation in patients with acute coronary syndromes
Eur. Heart J., June 2, 2002; 23(12): 941 - 947.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Schulman, D. R. Thiemann, P. Ouyang, N. C. Chandra, D. S. Schulman, S. E. Reis, M. Terrin, S. Forman, C. Piva de Albuquerque, R. D. Bahr, et al.
Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Valensi, R.-N. Sachs, B. Harfouche, B. Lormeau, J. Paries, E. Cosson, F. Paycha, M. Leutenegger, and J.-R. Attali
Predictive Value of Cardiac Autonomic Neuropathy in Diabetic Patients With or Without Silent Myocardial Ischemia
Diabetes Care, February 1, 2001; 24(2): 339 - 343.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
S. G. Goodman, A. Barr, A. Sobtchouk, M. Cohen, G. J. Fromell, L. Laperriere, C. Hill, A. Langer, and for the Canadian Efficacy and Safety of Subcutaneo
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy
J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1507 - 1513.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Weber, H. Schneider, T. von Arnim, and W. Urbaszek
Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris: Influence of drug therapy and prognostic value
Eur. Heart J., January 1, 1999; 20(1): 38 - 50.
[Abstract] [PDF]


Home page
NEJMHome page
D. T. Mangano, E. L. Layug, A. Wallace, I. Tateo, and The Multicenter Study of Perioperative Ischemia Re
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
N. Engl. J. Med., December 5, 1996; 335(23): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. P. Schulman, P. J. Goldschmidt-Clermont, E. J. Topol, R. M. Califf, F. I. Navetta, J. T. Willerson, N. C. Chandra, A. D. Guerci, J. J. Ferguson, R. A. Harrington, et al.
Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable Angina: A Randomized Multicenter Trial
Circulation, November 1, 1996; 94(9): 2083 - 2089.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
F. L. Dini, C. Volterrani, A. Giaconi, A. Azzarelli, M. Lunardi, and D. Bernardi
Prior Myocardial Infarction and Prognostic Outcome in Patients with Unstable Angina in a Postdischarge Follow-up
Angiology, April 1, 1996; 47(4): 321 - 327.
[Abstract] [PDF]


Home page
NEJMHome page
J. B. Gill, J. A. Cairns, R. S. Roberts, L. Costantini, B. J. Sealey, E. F. Fallen, C. W. Tomlinson, and M. Gent
Prognostic Importance of Myocardial Ischemia Detected by Ambulatory Monitoring Early after Acute Myocardial Infarction
N. Engl. J. Med., January 11, 1996; 334(2): 65 - 71.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Liuzzo, L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, and A. Maseri
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
N. Engl. J. Med., August 18, 1994; 331(7): 417 - 424.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
W. S. Aronow, S. Epstein, and M. Koenigsberg
Usefulness of Echocardiographic Left Ventricular Hypertrophy and Silent Ischemia in Predicting New Cardiac Events in Elderly Patients With Systemic Hypertension or Coronary Artery Disease
Angiology, March 1, 1990; 41(3): 189 - 193.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1987 by the American College of Cardiology Foundation.